[Fungal infectivities of implanted catheters due to Candida sp. Biofilms formation and resistance]

S M L Seddiki1, Z Boucherit-Otmani2, K Boucherit3

  • 1Laboratoire antibiotique antifongique, physico-chimie, synthèse et activité biologique, université de Tlemcen, BP 119, 13000 Imama, Tlemcen, Algérie; University center of Naâma, BP 66, 45000 Naâma, Algérie.

Abstract

Insights

Candida biofilms on catheters form complex structures, significantly increasing resistance to antifungal drugs like amphotericin B and fluconazole. This highlights challenges in treating candidemia and invasive fungal infections.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Biomaterials Science

Background:

  • Candidemia is a common hospital-acquired fungal infection.
  • Candida biofilms on medical devices like catheters pose a significant risk.
  • Biofilm formation confers high resistance to antifungal agents.

Purpose of the Study:

  • To evaluate the antifungal resistance of Candida biofilms on catheters.
  • To compare the minimum inhibitory concentrations (MIC) of planktonic and sessile Candida cells.
  • To investigate the structural characteristics of in vivo Candida biofilms.

Main Methods:

  • Scanning electron microscopy (SEM) was used to visualize in vivo biofilm structures on catheters.
  • Minimum inhibitory concentrations (MIC) for planktonic cells were determined.
  • Colony-forming unit (CFU) assays or similar methods were used to determine the minimum inhibitory concentrations of sessile cells (CIMS).
  • Resistance was assessed against amphotericin B (AmB) and fluconazole (FLZ).

Main Results:

  • SEM revealed complex structural formations of Candida biofilms on catheter surfaces.
  • Sessile Candida cells within biofilms exhibited significantly increased resistance compared to planktonic cells.
  • CIMS showed a 32-fold increase in resistance to AmB and a 128-fold increase to FLZ compared to MICs.

Conclusions:

  • Catheters provide a favorable environment for Candida biofilm development.
  • The complex structure of these biofilms enhances the resistance of sessile cells to conventional antifungal agents.
  • These findings underscore the therapeutic challenges associated with treating biofilm-associated candidemia.